These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29469969)

  • 1. Nanobody-Enabled Reverse Pharmacology on G-Protein-Coupled Receptors.
    Pardon E; Betti C; Laeremans T; Chevillard F; Guillemyn K; Kolb P; Ballet S; Steyaert J
    Angew Chem Int Ed Engl; 2018 May; 57(19):5292-5295. PubMed ID: 29469969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology.
    Nelson CP; Challiss RA
    Biochem Pharmacol; 2007 Mar; 73(6):737-51. PubMed ID: 17046719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses.
    Baker JG; Hall IP; Hill SJ
    Mol Pharmacol; 2003 Sep; 64(3):679-88. PubMed ID: 12920204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-protein coupled receptors: SAR analyses of neurotransmitters and antagonists.
    Kuo CL; Wang RB; Shen LJ; Lien LL; Lien EJ
    J Clin Pharm Ther; 2004 Jun; 29(3):279-98. PubMed ID: 15153091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Generic G Protein Peptidomimetics Able to Stabilize Active State G
    Mannes M; Martin C; Triest S; Pia Dimmito M; Mollica A; Laeremans T; Menet CJ; Ballet S
    Angew Chem Int Ed Engl; 2021 Apr; 60(18):10247-10254. PubMed ID: 33596327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy.
    Scharf MM; Bünemann M; Baker JG; Kolb P
    Mol Pharmacol; 2019 Dec; 96(6):851-861. PubMed ID: 31624135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell signalling: Binding the receptor at both ends.
    Sprang SR
    Nature; 2011 Jan; 469(7329):172-3. PubMed ID: 21228868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.
    Di Pizio A; Levit A; Slutzki M; Behrens M; Karaman R; Niv MY
    Methods Cell Biol; 2016; 132():401-27. PubMed ID: 26928553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligands of Adrenergic Receptors: A Structural Point of View.
    Wu Y; Zeng L; Zhao S
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors.
    Prather PL
    Sci STKE; 2004 Jan; 2004(215):pe1. PubMed ID: 14722344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of inverse agonism in a G protein-coupled receptor.
    Vilardaga JP; Steinmeyer R; Harms GS; Lohse MJ
    Nat Chem Biol; 2005 Jun; 1(1):25-8. PubMed ID: 16407989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between G-Protein-Stabilized Agonist-GPCR Complexes and their Nanobody-Stabilized Equivalents.
    Saleh N; Ibrahim P; Clark T
    Angew Chem Int Ed Engl; 2017 Jul; 56(31):9008-9012. PubMed ID: 28481446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies to Study G Protein-Coupled Receptor Structure and Function.
    Manglik A; Kobilka BK; Steyaert J
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():19-37. PubMed ID: 27959623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of conformational ensembles of seven transmembrane receptors in functional selectivity.
    Vaidehi N; Kenakin T
    Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse agonism: the classic concept of GPCRs revisited [Review].
    Sato J; Makita N; Iiri T
    Endocr J; 2016 Jun; 63(6):507-14. PubMed ID: 26961122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors.
    Vedel L; Bräuner-Osborne H; Mathiesen JM
    J Biomol Screen; 2015 Aug; 20(7):849-57. PubMed ID: 25851033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.